945PA phase I/II study of chemo-immunotherapy with durvalumab (durva) and pegylated liposomal doxorubicin (PLD) in platinum-resistant recurrent ovarian cancer (PROC)

Saved in:

Bibliographic Details
Published in:	Annals of oncology Vol. 29; no. suppl_8
Main Authors:	O'Cearbhaill, R E, Wolfer, A, Disilvestro, P, O'Malley, D M, Sabbatini, P, Shohara, L, Schwarzenberger, P O, Ricciardi, T, Macri, M, Ryan, A, Venhaus, R R, Bryan, J K, Wong, P, Homicsko, K, Kandalaft, L, Rusakiewicz, S, Harari, A, Monk, B J, Coukos, G
Format:	Journal Article
Language:	English
Published:	Oxford University Press 01-10-2018
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0923-7534 1569-8041
DOI:	10.1093/annonc/mdy285.153